NCT05938790

Brief Summary

The research will find out if using portable ultrasound devices by nurses can make it quicker to get babies from 24 to 32 weeks on the doppler monitor.

Trial Health

15
At Risk

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Trial has exceeded expected completion date
Timeline
Completed

Started Oct 2023

Status
withdrawn

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

First Submitted

Initial submission to the registry

May 25, 2023

Completed
2 months until next milestone

First Posted

Study publicly available on registry

July 10, 2023

Completed
4 months until next milestone

Study Start

First participant enrolled

October 26, 2023

Completed
1.4 years until next milestone

Primary Completion

Last participant's last visit for primary outcome

March 19, 2025

Completed
Same day until next milestone

Study Completion

Last participant's last visit for all outcomes

March 19, 2025

Completed
Last Updated

April 11, 2025

Status Verified

April 1, 2025

Enrollment Period

1.4 years

First QC Date

May 25, 2023

Last Update Submit

April 8, 2025

Conditions

Keywords

fetal monitoringobstetric triagepoint of care ultrasoundantenatal monitoring

Outcome Measures

Primary Outcomes (1)

  • Time to signal of fetal heart rate

    How long does it take for the external fetal monitor to pick up a continuous fetal heart rate signal. From time fetal monitor is turned on to the successful detection of fetal heart rate, recorded in minutes and seconds up to 100 days.

    From date of randomization until the date of first successful detection of fetal heart rate up to 100 days

Secondary Outcomes (1)

  • Physician paged to bedside

    From date of randomization until the date of first successful detection of fetal heart rate up to 100 days

Study Arms (2)

Continuous Fetal Monitoring

ACTIVE COMPARATOR

A nurse will turn on the Obix cEFM machine which will automatically register the patient in the Obix system and begin the timer which will be used to measure time to fetal monitoring. The patient will lay on the triage stretcher and the continuous external fetal monitor doppler probe will be placed on the abdomen over the fetus, identified via Leopold maneuvers. Nurses will adjust the cEFM as needed until a full fetal heart rate signal is obtained. At this point the timer will be counted as the time to monitor. Once the fetal heart rate signal is obtained via cEFM, the patient's participation in the study ends.

Other: Continuous Fetal Monitoring

Point of Care Handheld Ultrasound

EXPERIMENTAL

A nurse will turn on the Obix cEFM machine which will automatically register the patient in the Obix system and begin the timer which will be used to measure time to fetal monitoring. The patient will lay on the triage stretcher and a Butterfly ultrasound (Figure 1) probe will be used with a secure institutional Ipad by the triage nurse to identify the fetal position and location of the fetal heart. All images are deidentified and not stored since it will be a live real time aid to obtain a fetal heart tracing via cEFM. The cEFM will be placed on the maternal abdomen according to the imaging obtained by the ultrasound. Once fetal heart rate signal is obtained via cEFM, the patient's participation in the study ends.

Other: Point of Care Handheld Ultrasound

Interventions

Fetal doppler used to monitor fetal heart rate in triage

Continuous Fetal Monitoring

Point of Care Handheld Ultrasound

Point of Care Handheld Ultrasound

Eligibility Criteria

Age18 Years - 50 Years
Sexfemale
Healthy VolunteersYes
Age GroupsAdult (18-64)

You may qualify if:

  • Patients will be included in the study if they meet the following criteria:
  • Women maternal age 18 to age 50
  • Gestational age between 24 weeks 0 days and 32 weeks 0 days
  • Singleton pregnancy.

You may not qualify if:

  • Patients will be excluded if:
  • They are incarcerated
  • Are below the age of 18
  • If the fetus has a known lethal anomaly and a decision has been made by the patient to decline fetal monitoring.

Contact the study team to confirm eligibility.

Sponsors & Collaborators

0

Study Design

Study Type
interventional
Phase
not applicable
Allocation
RANDOMIZED
Masking
NONE
Purpose
OTHER
Intervention Model
PARALLEL
Sponsor Type
OTHER
Responsible Party
SPONSOR

Study Record Dates

First Submitted

May 25, 2023

First Posted

July 10, 2023

Study Start

October 26, 2023

Primary Completion

March 19, 2025

Study Completion

March 19, 2025

Last Updated

April 11, 2025

Record last verified: 2025-04

Data Sharing

IPD Sharing
Will not share